{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:22:58Z","timestamp":1791174178403,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.coph.2012.07.005","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T01:34:47Z","timestamp":1343180087000},"page":"551-555","source":"Crossref","is-referenced-by-count":57,"title":["Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance"],"prefix":"10.1016","volume":"12","author":[{"given":"Michel","family":"Pieren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Tigges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2012.07.005_bib0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.drup.2011.02.006","article-title":"The global need for effective antibiotics-moving towards concerted action","volume":"14","author":"Cars","year":"2011","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.coph.2012.07.005_bib0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.coph.2012.07.005_bib0015","first-page":"1","article-title":"Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections","volume":"2","author":"Nijnik","year":"2009","journal-title":"Emerg Health Threats J"},{"key":"10.1016\/j.coph.2012.07.005_bib0020","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/IAI.00741-10","article-title":"Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii","volume":"79","author":"McConnell","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.coph.2012.07.005_bib0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/med.20145","article-title":"Inhibitors and antagonists of bacterial quorum sensing","volume":"29","author":"Ni","year":"2009","journal-title":"Med Res Rev"},{"key":"10.1016\/j.coph.2012.07.005_bib0030","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.idc.2011.07.006","article-title":"Monoclonal antibodies in infectious diseases: clinical pipeline in 2011","volume":"25","author":"Ter Meulen","year":"2011","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.coph.2012.07.005_bib0035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.mib.2011.09.002","article-title":"Heterogeneous bacterial persisters and engineering approaches to eliminate them","volume":"14","author":"Allison","year":"2011","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.coph.2012.07.005_bib0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/138920110790725410","article-title":"Phage therapy pharmacology","volume":"11","author":"Abedon","year":"2010","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.coph.2012.07.005_bib0045","doi-asserted-by":"crossref","first-page":"9994","DOI":"10.1073\/pnas.0800663105","article-title":"A synthetic mammalian gene circuit reveals antituberculosis compounds","volume":"105","author":"Weber","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2012.07.005_bib0050_1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drup.2011.02.001","article-title":"Fighting bacterial infections-future treatment options","volume":"14","author":"Fernebro","year":"2011","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.coph.2012.07.005_bib0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.coph.2011.07.008","article-title":"Resistance drives antibacterial drug development","volume":"11","author":"Theuretzbacher","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.coph.2012.07.005_bib0060","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cell.2007.03.004","article-title":"Molecular mechanisms of antibacterial multidrug resistance","volume":"128","author":"Alekshun","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.coph.2012.07.005_bib0065_1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrmicro2319","article-title":"Antibiotic resistance and its cost: is it possible to reverse resistance?","volume":"8","author":"Andersson","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coph.2012.07.005_bib0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/CMR.00015-06","article-title":"Modes and modulations of antibiotic resistance gene expression","volume":"20","author":"Depardieu","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.coph.2012.07.005_bib0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.mib.2011.08.003","article-title":"Combination therapies for combating antimicrobial resistance","volume":"14","author":"Fischbach","year":"2011","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.coph.2012.07.005_bib0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nchembio.559","article-title":"Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy","volume":"7","author":"Ejim","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.coph.2012.07.005_bib0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.mib.2009.12.011","article-title":"Evolution and phyletic distribution of two-component signal transduction systems","volume":"13","author":"Wuichet","year":"2010","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.coph.2012.07.005_bib0090_1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ja.2010.4","article-title":"Novel antibacterial compounds specifically targeting the essential WalR response regulator","volume":"63","author":"Gotoh","year":"2010","journal-title":"J Antibiot"},{"key":"10.1016\/j.coph.2012.07.005_bib0095","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2958.2010.07110.x","article-title":"A lipoprotein modulates activity of the MtrAB two-component system to provide intrinsic multidrug resistance, cytokinetic control and cell wall homeostasis in Mycobacterium","volume":"76","author":"Nguyen","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.coph.2012.07.005_bib0100","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cellsig.2011.03.015","article-title":"Inhibition of the signal transduction through the AtoSC system by histidine kinase inhibitors in Escherichia coli","volume":"23","author":"Theodorou","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.coph.2012.07.005_bib0105","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ja.2009.128","article-title":"Walkmycin B targets WalK (YycG), a histidine kinase essential for bacterial cell growth","volume":"63","author":"Okada","year":"2010","journal-title":"J Antibiot"},{"key":"10.1016\/j.coph.2012.07.005_bib0110","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1365-2958.2009.06826.x","article-title":"QseC-mediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli","volume":"73","author":"Kostakioti","year":"2009","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.coph.2012.07.005_bib0115","doi-asserted-by":"crossref","first-page":"16305","DOI":"10.1073\/pnas.0700025104","article-title":"Stimulus-dependent differential regulation in the Escherichia coli PhoQ\u2013PhoP system","volume":"104","author":"Miyashiro","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2012.07.005_bib0120","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2958.2009.06782.x","article-title":"The GacS\/GacA signal transduction system of Pseudomonas aeruginosa acts exclusively through its control over the transcription of the RsmY and RsmZ regulatory small RNAs","volume":"73","author":"Brencic","year":"2009","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.coph.2012.07.005_bib0125","doi-asserted-by":"crossref","first-page":"14570","DOI":"10.1073\/pnas.0903619106","article-title":"Targeting a bacterial stress response to enhance antibiotic action","volume":"106","author":"Lee","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2012.07.005_bib0130","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1016\/j.bmcl.2007.07.072","article-title":"Novel anti-infection agents: small-molecule inhibitors of bacterial transcription factors","volume":"17","author":"Bowser","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.coph.2012.07.005_bib0135","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1128\/IAI.01305-09","article-title":"Small molecule inhibitors of LcrF, a Yersinia pseudotuberculosis transcription factor, attenuate virulence and limit infection in a murine pneumonia model","volume":"78","author":"Garrity-Ryan","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.coph.2012.07.005_bib0140","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1073\/pnas.0611643104","article-title":"Virstatin inhibits dimerization of the transcriptional activator ToxT","volume":"104","author":"Shakhnovich","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2012.07.005_bib0145","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1093\/infdis\/jir858","article-title":"Drug-resistant tuberculosis \u2013 current dilemmas, unanswered questions, challenges, and priority needs","volume":"205","author":"Zumla","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coph.2012.07.005_bib0150","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nm.1950","article-title":"Synthetic EthR inhibitors boost antituberculous activity of ethionamide","volume":"15","author":"Willand","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2012.07.005_bib0155_1","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1021\/jm200076a","article-title":"Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors","volume":"54","author":"Flipo","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2012.07.005_bib0160","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tube.2005.07.005","article-title":"Insights into mechanisms of induction and ligands recognition in the transcriptional repressor EthR from Mycobacterium tuberculosis","volume":"86","author":"Frenois","year":"2006","journal-title":"Tuberculosis"},{"key":"10.1016\/j.coph.2012.07.005_bib0165","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of \u03b2-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.coph.2012.07.005_bib0170_1","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1128\/AAC.01525-09","article-title":"In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli","volume":"54","author":"Page","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2012.07.005_bib0175","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/AAC.00320-06","article-title":"Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics","volume":"50","author":"Wang","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2012.07.005_bib0180","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1365-2958.2008.06583.x","article-title":"Genome-wide regulon and crystal structure of BlaI (Rv1846c) from Mycobacterium tuberculosis","volume":"71","author":"Sala","year":"2009","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.coph.2012.07.005_bib0185","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1126\/science.1167498","article-title":"Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis","volume":"323","author":"Hugonnet","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.coph.2012.07.005_bib0190","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/INF.0b013e3182154b05","article-title":"Meropenem\/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis","volume":"30","author":"Dauby","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.coph.2012.07.005_bib0195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.coph.2012.07.005_bib0200","doi-asserted-by":"crossref","DOI":"10.1021\/cb200366u","article-title":"Inhibitors of aminoglycoside resistance activated in cells","author":"Vong","year":"2012","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.coph.2012.07.005_bib0205","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/cmdc.200700201","article-title":"Virtual screening and experimental verification to identify potential inhibitors of the ErmC methyltransferase responsible for bacterial resistance against macrolide antibiotics","volume":"3","author":"Feder","year":"2008","journal-title":"Chemmedchem"},{"key":"10.1016\/j.coph.2012.07.005_bib0210","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/jac\/dkg224","article-title":"Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy","volume":"51","author":"Van Bambeke","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.coph.2012.07.005_bib0215","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bbapap.2008.12.011","article-title":"Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria","volume":"1794","author":"Pag\u00e8s","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.coph.2012.07.005_bib0220","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jac\/dkq079","article-title":"Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria","volume":"65","author":"Piddock","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.coph.2012.07.005_bib0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","article-title":"Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy","volume":"45","author":"Lomovskaya","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2012.07.005_bib0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000077280","article-title":"A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates","volume":"50","author":"Coban","year":"2004","journal-title":"Chemotherapy"},{"key":"10.1016\/j.coph.2012.07.005_bib0235","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1128\/AAC.48.3.1043-1046.2004","article-title":"Inhibitors of antibiotic efflux in resistant Enterobacter aerogenes and Klebsiella pneumoniae strains","volume":"48","author":"Chevalier","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2012.07.005_bib0240","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1128\/AAC.48.11.4171-4176.2004","article-title":"Inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (VX-710) and timcodar (VX-853)","volume":"48","author":"Mullin","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2012.07.005_bib0245","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/clinids\/4.2.282","article-title":"Antibiotic synergism and antimicrobial combinations in clinical infections","volume":"4","author":"Eliopoulos","year":"2011","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.coph.2012.07.005_bib0250","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nature05685","article-title":"Antibiotic interactions that select against resistance","volume":"446","author":"Chait","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.coph.2012.07.005_bib0255","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1371\/journal.pcbi.1000796","article-title":"Optimal drug synergy in antimicrobial treatments","volume":"6","author":"Torella","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.coph.2012.07.005_bib0260","doi-asserted-by":"crossref","first-page":"E53","DOI":"10.1371\/journal.pbio.0020053","article-title":"New antibiotics\u2014resistance is futile","volume":"2","author":"Powledge","year":"2004","journal-title":"PLoS Biol"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489212001166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489212001166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T13:02:51Z","timestamp":1561986171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489212001166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1471489212001166"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2012.07.005","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}